NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE228934 Query DataSets for GSE228934
Status Public on Apr 08, 2024
Title IKKβ Inhibition Attenuates Epithelial Mesenchymal Transition of Human Stem Cell-Derived Retinal Pigment Epithelium
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Epithelial-mesenchymal transition (EMT), which is well known for its role in embryonic development, malignant transformation, and tumor progression, has also been implicated in a variety of retinal diseases, including proliferative vitreoretinopathy (PVR), age-related macular degeneration (AMD), and diabetic retinopathy. EMT of the retinal pigment epithelium (RPE), although important in the pathogenesis of these retinal conditions, is not well understood at the molecular level. We and others have shown that a variety of molecules, including the co-treatment of human stem cell-derived RPE monolayer cultures with transforming growth factor beta (TGF–β) and the inflammatory cytokine tumor necrosis factor alpha (TNF–α), can induce RPE–EMT; however, small molecule inhibitors of RPE–EMT have been less well studied. Here, we demonstrate that BAY651942, a small molecule inhibitor of nuclear factor kapa-B kinase subunit beta (IKKβ) that selectively targets NF-κB signaling, can modulate TGF–β/TNF–α-induced RPE–EMT. Next, we performed RNA-seq studies on BAY651942 treated hRPE monolayers to dissect altered biological pathways and signaling events. Further, we validated the effect of IKKβ inhibition on RPE–EMT-associated factors using a second IKKβ inhibitor, BMS345541, with RPE monolayers derived from an independent stem cell line. Our data highlights the fact that pharmacological inhibition of RPE–EMT restores RPE identity and may provide a promising approach for treating retinal diseases that involve RPE dedifferentiation and EMT.
 
Overall design We compared the transcriptomic profiles of human stem cell-derived RPE monolayer cultures co-treated with TGF–β/TNF–α and a small molecule (BAY651942) inhibitor of nuclear factor kapa-B kinase subunit beta (IKKβ)
 
Contributor(s) Sripathi SR, Hu M, Chakra Turaga R, Mikeasky R, Satyanarayana G, Cheng J, Duan Y, Maruotti J, Wahlin KJ, Berlinicke CA, Qian J, Esumi N, Zack DJ
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Apr 04, 2023
Last update date Apr 08, 2024
Contact name Srinivasa R. Sripathi
E-mail(s) ssripathi@rfsw.org
Phone 214-363-3911
Organization name Retina Foundation of the Southwest
Lab Henderson Ocular Stem Cell Laboratory
Street address 9600 N Central Expressway Suite 200
City Dallas
State/province Texas
ZIP/Postal code 75231
Country USA
 
Platforms (1)
GPL11154 Illumina HiSeq 2000 (Homo sapiens)
Samples (13)
GSM7143013 BAY65_16uM1
GSM7143014 BAY65_16uM2
GSM7143015 BAY65_32uM1
Relations
BioProject PRJNA952210

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE228934_Gene_FPKM_Bay65.csv.gz 1.9 Mb (ftp)(http) CSV
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap